Dyslipidaemia is a hallmark of chronic kidney disease (CKD), with insights from lipidomics studies suggesting that alterations in free fatty acid partitioning may contribute to CKD progression. This Review provides an introduction to lipidomics and discusses insights from lipidomics studies of relevance to CKD.
- Judy Baek
- Chenchen He
- Subramaniam Pennathur
